Stereotaxis Concludes $18 Million Financial Arrangement With Biosense Webster (PR Newswire)

yahoo.com     Jul 24, 2008            

Thursday July 24, 4:10 pm ET U.S. and Europe Magnetic Irrigated Catheter Regulatory Filings Completed Ahead of Schedule ST. LOUIS, July 24 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS - News ), announced today that it has amended its collaboration with Biosense Webster, Inc., Stereotaxis' partner in the development of ablation catheters used with its Niobe Magnetic Navigation System. Under the terms of the amended agreement, Biosense Webster will provide Stereotaxis a total of $18 million, comprised of advances against royalties on catheter sales and deferrals of ongoing research and development costs in connection with current and future products. The two companies have also agreed to co-promote and expand Stereotaxis' Odyssey Network, by granting Biosense Webster non-exclusive rights to use the Stereotaxis... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies